Celularity Inc. Payments of Stock Issuance Costs
Celularity Inc. (CELU) reported Payments of Stock Issuance Costs of $210.00 thousand for the 12-month period ending 2025-12-31, per its 10-K filed 2026-04-30.
Financial Statements › Cash Flow › Financing Activities
us-gaap:PaymentsOfStockIssuanceCosts · last filed 2026-04-30
- Celularity Inc. payments of stock issuance costs for the quarter ending 2019-12-31 was $0.00.
- Celularity Inc. payments of stock issuance costs for the quarter ending 2019-09-30 was $0.00.
- Celularity Inc. payments of stock issuance costs for the quarter ending 2019-06-30 was $505.72K.
- Celularity Inc. payments of stock issuance costs for the quarter ending 2019-03-31 was $5.15K.
- Celularity Inc. payments of stock issuance costs for fiscal 2025 was $210.00K.
- Celularity Inc. payments of stock issuance costs for fiscal 2019 was $510.87K.
| Period end | Payments of Stock Issuance Costs 1 month | Payments of Stock Issuance Costs 3 month | Payments of Stock Issuance Costs 4 month | Payments of Stock Issuance Costs 6 month | Payments of Stock Issuance Costs 9 month | Payments of Stock Issuance Costs 12 month |
|---|---|---|---|---|---|---|
| 2025-12-31 | $210.00K 10-K · filed 2026-04-30 | |||||
| 2019-12-31 | $0.00 derived: 10-K/A 12 month − 10-Q 9 month · filed 2021-05-24 | $0.00 derived: sum of 2 quarters · filed 2021-05-24 | $505.72K derived: sum of 3 quarters · filed 2021-05-24 | $510.87K 10-K/A · filed 2021-05-24 | ||
| 2019-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-16 | $505.72K derived: sum of 2 quarters · filed 2020-11-16 | $510.87K 10-Q · filed 2020-11-16 | |||
| 2019-06-30 | $505.72K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-13 | $510.87K 10-Q · filed 2020-08-13 | ||||
| 2019-03-31 | $5.15K 10-Q · filed 2020-05-15 | |||||
| 2018-12-31 | $149.75K 10-K · filed 2020-03-24 | |||||
| 2018-09-30 | $40.00K 10-Q · filed 2019-11-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 |